Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00884676
Show Display Options
Rank Status Study
1 Active, not recruiting Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: Ixabepilone;   Drug: Sunitinib

Indicates status has not been verified in more than two years